3M Company has reached a historic $7.35 billion settlement to resolve personal injury claims related to exposure to PFAS, toxic chemicals known as "forever chemicals." The settlement covers about 99% of existing claims, potentially benefiting 115,000 to 120,000 plaintiffs who allege health issues like kidney and testicular cancer from PFAS exposure, often linked to firefighting foam. This agreement marks a major milestone in nationwide litigation over chemical safety and corporate responsibility, with 3M paying over nine years to address these claims. The case highlights ongoing concerns about long-term health effects of PFAS and the legal rights of affected individuals.
3M Company shares surged 9.61% to USD 194.07 as of Nov 05, 2026 03:11 WIB on Pluang, reflecting strong market reaction to the historic $7.35 billion settlement over PFAS exposure claims. The stock's market cap stands at $91.31 billion with a dividend yield of 1.76%, while Pluang investors show a 61% buy activity. This trading activity highlights investor interest following the major legal resolution for 3M.
3M has agreed to a $7.35 billion settlement over nine years to resolve personal injury claims related to PFAS chemicals in firefighting foam. The deal covers about 99% of current claims involving up to 120,000 plaintiffs, but payments depend on a par...
3M has agreed to a $7.35 billion nominal settlement, with a present value of $5.8 billion, to resolve approximately 99% of PFAS-related personal injury claims involving up to 120,000 plaintiffs. This settlement reduces litigation uncertainty and alig...
3M Company is seeing strong revenue growth from data center partnerships with Microsoft and Amazon, supporting positive forecasts for fiscal years 2026 and 2027. The company also benefits from diversification into higher-growth sectors like spacecraf...
